Targeting miR-375 in gastric cancer

Bibliography

• Parkin DM, Bary F, Ferlay J, Pisani P. Global cancer statistics 2002. CA Cancer J Clin 2005;55:74-108
   PubMed Web of Science ®Google Scholar
• Forman D, Burley VJ. Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol 2006;20:633-49
   PubMed Web of Science ®Google Scholar
• World Health Organization. Cancer Incidence and Mortality Worldwide in 2008. GLOBOCAN 2008. Available from: http://globocan.iarc.fr/ [Last accessed 27 April 2011]
   Google Scholar
• Berrino F. The EUROCARE Study: strengths, limitations and perspectives of population- based, comparative survival studies. Ann Oncol 2003;14:v9-13
   Web of Science ®Google Scholar
• Ohta H, Noguchi Y, Takagi K, Early gastric carcinoma with special reference to macroscopic classification. Cancer 1987;60:1099-106
   Google Scholar
• Endo M, Habu H. Clinical studies of early gastric cancer. Hepatogastroenterol 1990;37:408-10
   PubMedGoogle Scholar
• Santoro E, Garofalo A, Scutari F, Early gastric cancer: total gastrectomy vs. distal resection. Results of a study of 271 cases. The Italian Stomach Cancer Group (A.C.O.I.-I.S.C.G.). Hepatogastroenterol 1991;38:427-9
   PubMedGoogle Scholar
• Moayyedi P, Axon AT, Feltbower R, Relation of adult lifestyle and socioeconomic factors to the prevalence of Helicobacter pylori infection. Int J Epidemiol 2002;31:624-31
   PubMed Web of Science ®Google Scholar
• Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49:347-53
   PubMed Web of Science ®Google Scholar
• Ekstrom AM, Held M, Hansson LE, Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 2001;121:784-91
   PubMed Web of Science ®Google Scholar
• Ekstrom AM, Serafini M, Nyren O, Dietary antioxidant intake and the risk of cardia cancer and noncardia cancer of the intestinal and diffuse types: a population-based case-control study in Sweden. Int J Cancer 2000;87:133-40
   PubMed Web of Science ®Google Scholar
• Naumann M, Crabtree JE. Helicobacter pylori-induced epithelial cell signalling in gastric carcinogenesis. Trends Microbiol 2004;12:29-36
   PubMed Web of Science ®Google Scholar
• Danaei G, Vander Hoorn S, Lopez AD, Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 2005;366:1784-93
   PubMed Web of Science ®Google Scholar
• Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993;75:843-54
   PubMed Web of Science ®Google Scholar
• Pasquinelli AE, Reinhart BJ, Slack F, Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 2000;408:86-9
   PubMed Web of Science ®Google Scholar
• Reinhart BJ, Slack FJ, Basson M, The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000;403:901-6
   PubMed Web of Science ®Google Scholar
• Kozomara A, Griffiths-Jones S. MiRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011;39:D152-7
   PubMed Web of Science ®Google Scholar
• Ambros V. MicroRNAs: tiny regulators with great potential. Cell 2001;107:823-26
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009;136:215-33
   PubMed Web of Science ®Google Scholar
• Valencia-Sanchez MA, Liu J, Hannon GJ, Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 2006;20:515-24
   PubMed Web of Science ®Google Scholar
• Carmell MA, Xuan Z, Zhang MQ, The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis. Genes Dev 2002;16:2733-42
   PubMed Web of Science ®Google Scholar
• Lai EC. Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet 2002;30:363-4
   PubMed Web of Science ®Google Scholar
• Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007;318:1931-4
   PubMed Web of Science ®Google Scholar
• Orom UA, Nielsen FC, Lund AH. MicroRNA-10a binds the 5′UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell 2008;30:460-71
   PubMed Web of Science ®Google Scholar
• Henke JI, Goergen D, Zheng J, MicroRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J 2008;27:3300-10
   PubMed Web of Science ®Google Scholar
• Niepmann M. Activation of hepatitis C virus translation by a liver-specific microRNA. Cell Cycle 2009;8:1473-7
   PubMed Web of Science ®Google Scholar
• Tsai NP, Lin YL, Wei LN. MicroRNA mir-346 targets the 5′-untranslated region of receptor-interacting protein 140 (RIP140) mRNA and up-regulates its protein expression. Biochem J 2009;424:411-18
   Google Scholar
• Moretti F, Thermann R, Hentze MW. Mechanism of translational regulation by miR-2 from sites in the 5′ untranslated region or the open reading frame. RNA 2010;16:2493-502
   Google Scholar
• Wang WX, Wilfred BR, Xie K, Individual microRNAs (miRNAs) display distinct mRNA targeting "rules". RNA Biol 2010;7:373-80
   PubMed Web of Science ®Google Scholar
• Shin C, Nam JW, Farh KK, Expanding the microRNA targeting code: functional sites with centered pairing. Mol Cell 2010;38:789-802
   PubMed Web of Science ®Google Scholar
• Petrocca F, Visone R, Onelli MR, E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 2008;13:272-86
   PubMed Web of Science ®Google Scholar
• Brennecke J, Hipfner DR, Stark A, Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 2003;113:25-36
   PubMed Web of Science ®Google Scholar
• Chen CZ, Li L, Lodish HF, MicroRNAs modulate hematopoietic lineage differentiation. Science 2004;303:83-6
   PubMed Web of Science ®Google Scholar
• Schratt GM, Tuebing F, Nigh EA, A brain-specific microRNA regulates dendritic spine development. Nature 2006;439:283-9
   PubMed Web of Science ®Google Scholar
• Murakami Y, Yasuda T, Saigo K, Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006;25:2537-45
   PubMed Web of Science ®Google Scholar
• Iorio MV, Ferracin M, Liu CG, MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005;65:7065-70
   PubMed Web of Science ®Google Scholar
• Cummins JM, He Y, Leary RJ, The colorectal microRNAome. Proc Natl Acad Sci USA 2006;103:3687-92
   PubMed Web of Science ®Google Scholar
• Schepeler T, Reinert JT, Ostenfeld MS, Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 2008;68:6416-24
   PubMed Web of Science ®Google Scholar
• Iorio MV, Visone R, Di Leva G, MicroRNA signatures in human ovarian cancer. Cancer Res 2007;67:8699-707
   PubMed Web of Science ®Google Scholar
• Zhang L, Volinia S, Bonome T, Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci USA 2008;105:7004-9
   PubMed Web of Science ®Google Scholar
• Yu SL, Chen HY, Chang GC, MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 2008;13:48-57
   PubMed Web of Science ®Google Scholar
• Yanaihara N, Caplen N, Bowman E, Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006;9:189-98
   PubMed Web of Science ®Google Scholar
• Du Y, Xu Y, Ding L, Down-regulation of miR-141 in gastric cancer and its involvement in cell growth. J Gastroenterol 2009;44:556-61
   PubMed Web of Science ®Google Scholar
• Ding L, Xu Y, Zhang W, MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res 2010;20:784-93
   PubMed Web of Science ®Google Scholar
• Chen Z, Zeng H, Guo Y, miRNA-145 inhibits non-small cell lung cancer cells proliferation by targeting c-Myc. J Exp Clin Cancer Res 2010;29:151
   PubMed Web of Science ®Google Scholar
• Wu J, Qian J, Li C, miR-129 regulates cell proliferation by downregulating Cdk6 expression. Cell Cycle 2010;9:1809-18
   PubMed Web of Science ®Google Scholar
• Tsang WP, Ng EK, Ng SS, Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis 2010;31:350-8
   PubMed Web of Science ®Google Scholar
• Guo X, Guo L, Ji J, miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer. Biochem Biophys Res Commun 2010;398:1-6
   PubMed Web of Science ®Google Scholar
• Kojima K, Fujita Y, Nozawa Y, MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms. Prostate 2010;70:1501-12
   PubMed Web of Science ®Google Scholar
• Bonci D, Coppola V, Musumeci M, The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 2008;14:1271-7
   PubMed Web of Science ®Google Scholar
• Zhu W, Shan X, Wang T, miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Int J Cancer 2010;127:2520-9
   PubMed Web of Science ®Google Scholar
• Molitoris JK, McColl KS, Distelhorst CW. Glucocorticoid-mediated repression of the oncogenic microRNA cluster miR-17∼92 contributes to the induction of Bim and initiation of apoptosis. Mol Endocrinol 2010;25:409-20
   Google Scholar
• Terasawa K, Ichimura A, Sato F, Sustained activation of ERK1/2 by NGF induces microRNA-221 and 222 in PC12 cells. FEBS J 2009;276:3269-76
   PubMed Web of Science ®Google Scholar
• Mavrakis KJ, Wolfe AL, Oricchio E, Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia. Nat Cell Biol 2010;12:372-9
   PubMed Web of Science ®Google Scholar
• Kan T, Sato F, Ito T, The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology 2009;136:1689-700
   PubMed Web of Science ®Google Scholar
• Lwin T, Lin J, Choi YS, Follicular dendritic cell dependent drug resistance of non-Hodgkin lymphoma involves cell-adhesion-mediated Bim down-regulation through induction of microRNA-181a. Blood 2010;116:5228-36
   PubMed Web of Science ®Google Scholar
• Swarbrick A, Woods SL, Shaw A, MiR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma. Nat Med 2010;16:1134-40
   PubMed Web of Science ®Google Scholar
• Hu W, Chan CS, Wu R, Negative regulation of tumor suppressor p53 by microRNA miR-504. Mol Cell 2010;38:689-99
   PubMed Web of Science ®Google Scholar
• Yamakuchi M, Lotterman CD, Bao C, P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis. Proc Natl Acad Sci USA 2010;107:6334-9
   PubMed Web of Science ®Google Scholar
• Cha ST, Chen PS, Johansson G, MicroRNA-519c suppresses hypoxia-inducible factor-1alpha expression and tumor angiogenesis. Cancer Res 2010;70:2675-85
   PubMed Web of Science ®Google Scholar
• Fang L, Deng Z, Shatseva T, MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-beta8. Oncogene 2010;30:806-21
   PubMed Web of Science ®Google Scholar
• Fish JE, Santoro MM, Morton SU, miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 2008;15:272-84
   PubMed Web of Science ®Google Scholar
• Wang S, Aurora AB, Johnson BA, The endothelial-specific microRNA governs vascular integrity and angiogenesis. Dev Cell 2008;15:261-71
   PubMed Web of Science ®Google Scholar
• Wang X, Tang S, Le SY, Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS ONE 2008;3:e2557
   PubMed Web of Science ®Google Scholar
• Feng R, Chen X, Yu Y, miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett 2010;298:50-63
   PubMed Web of Science ®Google Scholar
• Zhang H, Li Y, Lai M. The microRNA network and tumor metastasis. Oncogene 2010;29:937-48
   PubMed Web of Science ®Google Scholar
• Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007;449:682-8
   PubMed Web of Science ®Google Scholar
• Tavazoie SF, Alarcon C, Oskarsson T, Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008;451:147-52
   PubMed Web of Science ®Google Scholar
• Burk U, Schubert J, Wellner U, A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 2008;9:582-9
   PubMed Web of Science ®Google Scholar
• Gregory PA, Bert AG, Paterson EL, The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008;10:593-601
   PubMed Web of Science ®Google Scholar
• Korpal M, Lee ES, Hu G, The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 2008;283:14910-14
   PubMed Web of Science ®Google Scholar
• Park SM, Gaur AB, Lengyel E, The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 2008;22:894-907
   PubMed Web of Science ®Google Scholar
• Wu WK, Lee CW, Cho CH, MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene 2010;29:5761-71
   PubMed Web of Science ®Google Scholar
• Saito Y, Hidekazu S, Toshifumi H. The role of microRNAs in gastrointestinal cancers. J Gastroenterol 2009;44:18-22
   PubMed Web of Science ®Google Scholar
• Matsushima K, Isomoto H, Inoue N, MicroRNA signatures in Helicobacter pylori-infected gastric mucosa. Int J Cancer 2011;128:361-70
   Google Scholar
• Wan HY, Guo LM, Liu T, Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma. Mol Cancer 2010;9:16
   PubMed Web of Science ®Google Scholar
• Xia L, Zhang D, Du R, miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 2008;123:372-9
   PubMed Web of Science ®Google Scholar
• Ueda T, Volinia S, Okumura H, Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 2010;11:136-46
   PubMed Web of Science ®Google Scholar
• Katada T, Ishiguro H, Kuwabara Y, MicroRNA expression profile in undifferentiated gastric cancer. Int J Oncol 2009;34:537-42
   PubMed Web of Science ®Google Scholar
• Takagi T, Iio A, Nakagawa Y, Decreased expression of microRNA-143 and -145 in human gastric cancers. Oncology 2009;77:12-21
   PubMed Web of Science ®Google Scholar
• Saito Y, Suzuki H, Tsugawa H, Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells. Oncogene 2009;28:2738-44
   PubMed Web of Science ®Google Scholar
• Zhang Z, Li Z, Gao C, miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest 2008;88:1358-66
   PubMed Web of Science ®Google Scholar
• Volinia S, Calin GA, Liu CG, A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006;103:2257-61
   PubMed Web of Science ®Google Scholar
• Lai KW, Koh KX, Loh M, MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer. Eur J Cancer 2010;46:1456-63
   PubMed Web of Science ®Google Scholar
• Wu Q, Jin H, Yang Z, MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. Biochem Biophys Res Commun 2010;392:340-5
   PubMed Web of Science ®Google Scholar
• Jiang Z, Guo J, Xiao B, Increased expression of miR-421 in human gastric carcinoma and its clinical association. J Gastroenterol 2010;45:17-23
   PubMed Web of Science ®Google Scholar
• Motoyama K, Inoue H, Nakamura Y, Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family. Clin Cancer Res 2008;14:2334-40
   PubMed Web of Science ®Google Scholar
• Tsukamoto Y, Nakada C, Noguchi T, MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res 2010;70:2339-49
   PubMed Web of Science ®Google Scholar
• Ando T, Yoshida T, Enomoto S, DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect. Int J Cancer 2009;124:2367-74
   PubMed Web of Science ®Google Scholar
• Zheng ZH, Sun XJ, Fu WN, Decreased expression of DICER1 in gastric cancer. Chin Med J (Engl) 2007;120:2099-104
   PubMed Web of Science ®Google Scholar
• Tchernitsa O, Kasajima A, Schafer R, Systematic evaluation of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression. J Pathol 2010;222:310-19
   PubMed Web of Science ®Google Scholar
• Poy MN, Eliasson L, Krutzfeldt J, A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004;432:226-30
   PubMed Web of Science ®Google Scholar
• Baroukh NN, Van Obberghen E. Function of microRNA-375 and microRNA-124a in pancreas and brain. FEBS J 2009;276:6509-21
   Google Scholar
• Keller DM, McWeeney S, Arsenlis A, Characterization of pancreatic transcription factor Pdx-1 binding sites using promoter microarray and serial analysis of chromatin occupancy. J Biol Chem 2007;282:32084-92
   Google Scholar
• Kloosterman WP, Lagendijk AK, Ketting RF, Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development. PLoS Biol 2007;5:e203
   PubMed Web of Science ®Google Scholar
• Poy MN, Hausser J, Trajkovski M, miR-375 maintains normal pancreatic alpha- and beta-cell mass. Proc Natl Acad Sci USA 2009;106:5813-18
   PubMed Web of Science ®Google Scholar
• Li Y, Xu X, Liang Y, miR-375 enhances palmitate-induced lipoapoptosis in insulin-secreting NIT-1 cells by repressing myotrophin (V1) protein expression. Int J Clin Exp Pathol 2010;3:254-64
   PubMedGoogle Scholar
• El Ouaamari A, Baroukh N, Martens GA, miR-375 targets 3′-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells. Diabetes 2008;57:2708-17
   PubMed Web of Science ®Google Scholar
• Landgraf P, Rusu M, Sheridan R, A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007;129:1401-14
   PubMed Web of Science ®Google Scholar
• Wang Y, Weng T, Gou D, Identification of rat lung-specific microRNAs by micoRNA microarray: valuable discoveries for the facilitation of lung research. BMC Genomics 2007;8:29
   PubMed Web of Science ®Google Scholar
• Abdelmohsen K, Hutchison ER, Lee EK, miR-375 inhibits differentiation of neurites by lowering HuD levels. Mol Cell Biol 2010;30:4197-210
   PubMed Web of Science ®Google Scholar
• Zhang H, Mishra A, Chintagari NR, Micro-RNA-375 inhibits lung surfactant secretion by altering cytoskeleton reorganization. IUBMB Life 2010;62:78-83
   PubMed Web of Science ®Google Scholar
• Avissar M, Christensen BC, Kelsey KT, MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin Cancer Res 2009;15:2850-5
   PubMed Web of Science ®Google Scholar
• Avissar M, McClean MD, Kelsey KT, MicroRNA expression in head and neck cancer associates with alcohol consumption and survival. Carcinogenesis 2009;30:2059-63
   PubMed Web of Science ®Google Scholar
• Mathe EA, Nguyen GH, Bowman ED, MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res 2009;15:6192-200
   PubMed Web of Science ®Google Scholar
• Bhatti I, Lee A, James V, Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma. J Gastrointest Surg 2010;15:199-208
   PubMed Web of Science ®Google Scholar
• Ladeiro Y, Couchy G, Balabaud C, MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 2008;47:1955-63
   PubMed Web of Science ®Google Scholar
• Liu AM, Poon RT, Luk JM. MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties. Biochem Biophys Res Commun 2010;394:623-7
   PubMed Web of Science ®Google Scholar
• Furuta M, Kozaki KI, Tanaka S, miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2010;31:766-76
   PubMed Web of Science ®Google Scholar
• Li LM, Hu ZB, Zhou ZX, Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res 2010;70:9798-807
   PubMed Web of Science ®Google Scholar
• Yu L, Todd NW, Xing L, Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers. Int J Cancer 2010;127:2870-8
   PubMed Web of Science ®Google Scholar
• Lebanony D, Benjamin H, Gilad S, Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J Clin Oncol 2009;27:2030-7
   PubMed Web of Science ®Google Scholar
• de Souza Rocha Simonini P, Breiling A, Gupta N, Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. Cancer Res 2010;70:9175-84
   PubMed Web of Science ®Google Scholar
• Brooks AJ, Waters MJ. The growth hormone receptor: mechanism of activation and clinical implications. Nat Rev Endocrinol 2010;6:515-25
   PubMed Web of Science ®Google Scholar
• Garzon R, Marcucci G, Croce CM. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 2010;9:775-89
   PubMed Web of Science ®Google Scholar
• Verma A, Kambhampati S, Parmar S, Platanias LC. Jak family of kinases in cancer. Cancer Metastasis Rev 2003;22:423-34
   PubMed Web of Science ®Google Scholar
• Godeny MD, Sayeski PP. Jak2 tyrosine kinase and cancer: how good cells get HiJAKed. Anticancer Agents Med Chem 2007;7:643-50
   PubMed Web of Science ®Google Scholar
• Zeng X, Xu H, Glazer RI. Transformation of mammary epithelial cells by 3-phosphoinositide-dependent protein kinase-1 (PDK1) is associated with the induction of protein kinase Calpha. Cancer Res 2002;62:3538-43
   PubMed Web of Science ®Google Scholar
• Makris C, Voisin L, Giasson E, The Rb-family protein p107 inhibits translation by a PDK1-dependent mechanism. Oncogene 2002;21:7891-6
   PubMed Web of Science ®Google Scholar
• Lu J, Guo H, Treekitkarnmongkol W, 14-3-3zeta Cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition. Cancer Cell 2009;16:195-207
   PubMed Web of Science ®Google Scholar
• Levine RL, Pardanani A, Tefferi A, Gilliland DG. Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders. Nat Rev Cancer 2007;7:673-83
   PubMed Web of Science ®Google Scholar
• Baxter EJ, Scott LM, Campbell PJ, Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005;365:1054-61
   PubMed Web of Science ®Google Scholar
• Hedvat M, Huszar D, Herrmann A, The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors. Cancer Cell 2009;16:487-97
   PubMed Web of Science ®Google Scholar
• Levine RL, Wadleigh M, Cools J, Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 2005;7:387-97
   PubMed Web of Science ®Google Scholar
• James C, Ugo V, Le Couedic JP, A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 2005;434:1144-8
   PubMed Web of Science ®Google Scholar
• Wernig G, Kharas MG, Okabe R, Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera. Cancer Cell 2008;13:311-20
   PubMed Web of Science ®Google Scholar
• Lipka DB, Hoffmann LS, Heidel F, LS104, A non-ATP-competitive small-molecule inhibitor of JAK2, is potently inducing apoptosis in JAK2V617F-positive cells. Mol Cancer Ther 2008;7:1176-84
   PubMed Web of Science ®Google Scholar
• Kumar C, Purandare AV, Lee FY, Lorenzi MV. Kinase drug discovery approaches in chronic myeloproliferative disorders. Oncogene 2009;28:2305-13
   PubMed Web of Science ®Google Scholar
• Zhang J, Yang PL, Gray NS. Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer 2009;9:28-39
   PubMed Web of Science ®Google Scholar
• Chun-Zhi Z, Lei H, An-Ling Z, MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer 2010;10:367
   PubMed Web of Science ®Google Scholar
• Trang P, Medina PP, Wiggins JF, Regression of murine lung tumors by the let-7 microRNA. Oncogene 2010;29:1580-7
   PubMed Web of Science ®Google Scholar
• Wahid F, Shehzad A, Khan T, MicroRNAs: Synthesis, mechanism, function, and recent clinical trials. Biochim Biophys Acta 2010;1803:1231-43
   PubMed Web of Science ®Google Scholar
• Lanford RE, Hildebrandt-Eriksen ES, Petri A, Therapeutic silencing of microrna-122 in primates with chronic hepatitis C virus infection. Science 2010;327:198-201
   PubMed Web of Science ®Google Scholar
• Product pipeline: delivering therapies for patients with unmet medical needs. Hørsholm, Denmark: Santaris Pharma A/S, 2010. Available from: http://www.santaris.com/product-pipeline. [Last accessed 27 April 2011]
   Google Scholar
• Zhu LH, Liu T, Tang H, MicroRNA-23a promotes the growth of gastric adenocarcinoma cell line MGC803 and downregulates interleukin-6 receptor. FEBS J 2010;277:3726-34
   PubMed Web of Science ®Google Scholar
• Song G, Zeng H, Li J, miR-199a regulates the tumor suppressor mitogen-activated protein kinase kinase kinase 11 in gastric cancer. Biol Pharm Bull 2010;33:1822-7
   PubMed Web of Science ®Google Scholar
• Cho WJ, Shin JM, Kim JS, miR-372 regulates cell cycle and apoptosis of ags human gastric cancer cell line through direct regulation of LATS2. Mol Cells 2009;28:521-7
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhu W, Zhang J, MicroRNA-650 targets ING4 to promote gastric cancer tumorigenicity. Biochem Biophys Res Commun 2010;395:275-80
   PubMed Web of Science ®Google Scholar
• Wang HJ, Ruan HJ, He XJ, MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. Eur J Cancer 2010;46:2295-303
   PubMed Web of Science ®Google Scholar
• Hashimoto Y, Akiyama Y, Otsubo T, Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis. Carcinogenesis 2010;31:777-84
   PubMed Web of Science ®Google Scholar
• Tie J, Pan Y, Zhao L, MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet 2010;6:e1000879
   PubMed Web of Science ®Google Scholar
• Shinozaki A, Sakatani T, Ushiku T, Downregulation of microRNA-200 in EBV-associated gastric carcinoma. Cancer Res 2010;70:4719-27
   PubMedGoogle Scholar